MedTrace Logo

COVID-19 Booster Dose Reminder/Recall for Adolescents

NCT05571657 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4304

Last updated 2022-10-13

No results posted yet for this study

Summary

A single COVID-19 booster dose has been recommended in the United States for adolescents aged ≥12 years to enhance protection against SARS-CoV-2 infection. This study will assess the efficacy of a one-time reminder/recall for COVID-19 booster dose among eligible adolescents in a regional healthcare system.

Conditions

  • COVID-19 Vaccines

Interventions

BEHAVIORAL

Reminder/Recall Sent Via Preferred Method of Communication

Parents of 12-17 year-old patients due for COVID-19 booster dose will receive a one-time vaccine reminder/recall via the parent's preferred method of communication (mailed letter, text message, email)

Sponsors & Collaborators

  • Marshfield Clinic Research Foundation

    lead OTHER

Principal Investigators

  • Huong McLean, PhD · Marshfield Clinic Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-12
Primary Completion
2022-08-30
Completion
2022-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05571657 on ClinicalTrials.gov